Product Reports Resources Pricing Login Book a demo

Altus Pharmaceuticals

Biotech & Life Sciences · Independence, United States · Founded 1996 · IPO 2006

Information technology consulting firm with global impact MoreLess

Altus Technologies Corporation provides consulting and implementation services for IT. Our services include: • Data center consolidation and relocation services • IT mergers, migration planning and execution • Data center strategy • Enterprise IT Infrastructure roll-outs and refreshes • Technology refresh planning and implementations • Technical and Infrastructure project management (PMI Certified) • Physical and logical security (physical access systems, firewalls, network video systems) • Enterprise IT Architecture Our clients include many large firms in banking, insurance, healthcare, retail and manufacturing.

Valuation $1–2.5B
Revenue $100–500M
EBITDA $87M
Headcount <100
Total funding $100–500M

Talent graph

Altus Pharmaceuticals's talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Altus Pharmaceuticals's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Cystic Fibrosis Foundation
Series A 1 investor entered at this stage
Series B+ 1 investor entered at this stage

Global footprint

Where Altus Pharmaceuticals has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States85.7%
🇮🇳 India14.3%
2 countries shown
Web traffic by country
120 monthly visits
across markets
🇺🇸 United States83.3%
Top 1 markets shown

Patent intelligence

$2M patent portfolio · 1 active families

Estimated portfolio value
$2M
0.17% of market cap · 49.9× smaller than top peer Dicerna Pharmaceuticals ($100M)
1 active patent families
Where Altus Pharmaceuticals innovates BiochemistryChemical compositionCleaning agentCleansing AgentsCrystal

Where Altus Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Altus Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Altus Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Altus Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Altus Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.